1. Glucose impairs angiogenesis and promotes ventricular remodelling following myocardial infarction via upregulation of microRNA-17
   Meiling Yan et al, 2019, Experimental Cell Research CrossRef
2. Identification of novel protein kinase C-βII inhibitors: virtual screening, molecular docking and molecular dynamics simulation studies
   Bharat Kumar Reddy Sanapalli et al, 2022, Journal of Molecular Modeling CrossRef
3. Intermedin1–53 enhances angiogenesis and attenuates adverse remodeling following myocardial infarction by activating AMP-activated protein kinase
   Kankai Chen et al, 2017, Molecular Medicine Reports CrossRef
4. Ghrelin ameliorates impaired angiogenesis of ischemic myocardium through GHSR1a-mediated AMPK/eNOS signal pathway in diabetic rats
   Li Wang et al, 2015, Peptides CrossRef
5. Specific PKC βII inhibitor: one stone two birds in the treatment of diabetic foot ulcers
   Sushant Kumar Das et al, 2018, Bioscience Reports CrossRef
6. Wogonin and Alleviation of Hyperglycemia via Inhibition of DAG Mediated PKC Expression. A Brief Insight
   Shahzad Khan, 2021, Protein & Peptide Letters CrossRef
7. Effect of combined treatment with rosuvastatin and protein kinase Cβ2 inhibitor on angiogenesis following myocardial infarction in diabetic rats
   DONG HUANG et al, 2015, International Journal of Molecular Medicine CrossRef
8. High glucose/lysophosphatidylcholine levels stimulate extracellular matrix deposition in diabetic nephropathy via platelet‑activating factor receptor
   Su‑Xian Zhou et al, 2017, Molecular Medicine Reports CrossRef
9. High glucose-induced effects on Na+-K+-2Cl− cotransport and Na+/H+ exchange of blood-brain barrier endothelial cells: involvement of SGK1, PKCβII, and SPAK/OSR1
   Nicholas R. Klug et al, 2021, American Journal of Physiology-Cell Physiology CrossRef